80 FR 48546 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 156 (August 13, 2015)

Page Range		48546-48546
FR Document		2015-19940

Federal Register, Volume 80 Issue 156 (Thursday, August 13, 2015)

[Federal Register Volume 80, Number 156 (Thursday, August 13, 2015)]
[Notices]
[Page 48546]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-19940]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Board of Scientific Counselors, NIDDK.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the NATIONAL 
INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES, including 
consideration of personnel qualifications and performance, and the 
competence of individual investigators, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, NIDDK.
    Date: September 10-11, 2015.
    Open: September 10, 2015, 8:00 a.m. to 8:20 a.m.
    Agenda: Introductions and Overview.
    Place: National Institutes of Health, Building 5, Room 127, 5 
Memorial Drive, Bethesda, MD 20892.

    Closed: September 10, 2015, 8:20 a.m. to 5:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Building 5, Room 127, 5 
Memorial Drive, Bethesda, MD 20892.

    Closed: September 11, 2015, 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Building 5, Room 127, 5 
Memorial Drive, Bethesda, MD 20892.
    Contact Person: Michael W. Krause, Ph.D., Scientific Director, 
National Institute of Diabetes and Digestive and Kidney Diseases, 
National Institute of Health, Building 5, Room B104, Bethesda, MD 
20892-1818, (301) 402-4633, [email protected].

    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: August 10, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-19940 Filed 8-12-15; 8:45 am]
BILLING CODE 4140-01-P

48546 Federal Register / Vol. 80, No. 156 / Thursday, August 13, 2015 / Notices

Publication herpesviral infection of a host, The meeting will be closed to the
Kaur S, et al. Role of CD47 in triple comprising administering to the host an public as indicated below in accordance
negative breast cancer. FASEB J. 2015 effective amount of an inhibitor of the with the provisions set forth in section
April;29(1 Supplement); Abstract 890.5. EZH1/2 histone methyltransferase 552b(c)(6), Title 5 U.S.C., as amended
[http://www.fasebj.org/content/29/1_ activities. The application is not limited for the review, discussion, and
Supplement/890.5] to herpes simplex virus but rather is evaluation of individual intramural
Intellectual Property: HHS Reference applicable to other viral infections as programs and projects conducted by the
No. E–263–2014/0—US Application No. well. NATIONAL INSTITUTE OF DIABETES
62/062,675 filed October 10, 2014. AND DIGESTIVE AND KIDNEY
Potential Commercial Applications
DISEASES, including consideration of
Related Technologies • HSV therapeutics personnel qualifications and
• HHS Reference No. E–227–2006/ • HSV vaccines performance, and the competence of
5—US Patent 8,236,313 issued August Competitive Advantages individual investigators, the disclosure
7, 2012; US Patent 8,557,788 issued of which would constitute a clearly
October 15, 2013; US Patent 8,865,672 • Low-cost production unwarranted invasion of personal
issued October 21, 2014. • Ease of synthesis
privacy.
• HHS Reference No. E–153–2008/ Development Stage
0—US Patent No. 8,951,527 issued Name of Committee: Board of Scientific
February 10, 2015. • In vitro data available Counselors, NIDDK.
• HHS Reference No. E–086–2012/ • In vivo data available (animal) Date: September 10–11, 2015.
Inventors: Thomas M. Kristie and Open: September 10, 2015, 8:00 a.m. to
1—US Patent Application No. 61/ 8:20 a.m.
Jesse H. Arbuckle (NIAID)
735,701 filed December 11, 2012. Intellectual Property: HHS Reference Agenda: Introductions and Overview.
• HHS Reference No. E–296–2011/ Place: National Institutes of Health,
E–141–2015/0—US Provisional Patent
0—Application PCT/US2014/025989 Building 5, Room 127, 5 Memorial Drive,
Application 62/155,704 filed 01 May
filed March 13, 2014. Bethesda, MD 20892.
Licensing Contact: Jaime M. Greene; 2015
Closed: September 10, 2015, 8:20 a.m. to
301–435–5559; jaime.greene@ Related Technologies 5:00 p.m.
mail.nih.gov. • HHS Reference E–275–2008/0—US Agenda: To review and evaluate personal
Collaborative Research Opportunity: qualifications and performance, and
Patent Number 8,916,596 issued 23 Dec
The National Cancer Institute, Center for competence of individual investigators.
2014; US Application No. 14/543,321
Cancer Research, Laboratory of Place: National Institutes of Health,
filed 17 Nov 2014; PCT Application No. Building 5, Room 127, 5 Memorial Drive,
Pathology, is seeking statements of
PCT/US2009/051557 filed 23 Jul 2009 Bethesda, MD 20892.
capability or interest from parties • HHS Reference E–184–2010/0—US
interested in collaborative research to Patent Number 8,871,789 issued 28 Oct Closed: September 11, 2015, 8:00 a.m. to
further develop, evaluate or 4:00 p.m.
2014; PCT Application No. PCT/ Agenda: To review and evaluate personal
commercialize methods to differentiate US2011/044835 filed 21 Jul 2011
cancer stem cells. For collaboration qualifications and performance, and
Licensing Contact: Peter Soukas; 301– competence of individual investigators.
opportunities, please contact John D. 435–4646; ps193c@nih.gov Place: National Institutes of Health,
Hewes, Ph.D. at hewesj@mail.nih.gov.
Dated: August 7, 2015. Building 5, Room 127, 5 Memorial Drive,
Prevention or Treatment of Viral Richard U. Rodriguez, Bethesda, MD 20892.
Infections by Inhibition of the Histone Contact Person: Michael W. Krause, Ph.D.,
Acting Director, Office of Technology
Methyltransferases EZH1/2 Scientific Director, National Institute of
Transfer, National Institutes of Health.
Diabetes and Digestive and Kidney Diseases,
Description of Technology: Herpes [FR Doc. 2015–19912 Filed 8–12–15; 8:45 am] National Institute of Health, Building 5,
simplex viral infections, including BILLING CODE 4140–01–P Room B104, Bethesda, MD 20892–1818, (301)
herpes simplex virus type 1 (HSV–1) 402–4633, mwkrause@helix.nih.gov.
and type 2 (HSV–2), are exceptionally In the interest of security, NIH has
common worldwide. These viruses DEPARTMENT OF HEALTH AND instituted stringent procedures for entrance
establish lifelong persistent infections HUMAN SERVICES onto the NIH campus. All visitor vehicles,
with cycles of lytic reactivation to including taxicabs, hotel, and airport shuttles
produce recurrent diseases including National Institutes of Health will be inspected before being allowed on
oral and genital lesions, herpetic campus. Visitors will be asked to show one
keratitis/blindness, congenital- National Institute of Diabetes and form of identification (for example, a
developmental syndromes, and viral Digestive and Kidney Diseases; Notice government-issued photo ID, driver’s license,
encephalitis. Infection with HSV–2 of Meeting or passport) and to state the purpose of their
increases the rate of human Pursuant to section 10(d) of the visit.
immunodeficiency virus (HIV) Federal Advisory Committee Act, as (Catalogue of Federal Domestic Assistance
transmission in coinfected individuals. amended (5 U.S.C. App.), notice is Program Nos. 93.847, Diabetes,
DNA replication inhibitors are typically hereby given of a meeting of the Board Endocrinology and Metabolic Research;
used to treat herpesvirus infections. 93.848, Digestive Diseases and Nutrition
of Scientific Counselors, NIDDK.
Research; 93.849, Kidney Diseases, Urology
However, these compounds do not The meeting will be open to the and Hematology Research, National Institutes
completely suppress infection, viral public as indicated below, with of Health, HHS)
tkelley on DSK3SPTVN1PROD with NOTICES

shedding, reactivation from latency, and attendance limited to space available.
the inflammation that contributes to Individuals who plan to attend and Dated: August 10, 2015.
diseases such as keratitis. An unmet need special assistance, such as sign Melanie J. Gray,
need continues to exist for methods of language interpretation or other Program Analyst, Office of Federal Advisory
preventing or treating herpesviral reasonable accommodations, should Committee Policy.
infections. The application claims notify the Contact Person listed below [FR Doc. 2015–19940 Filed 8–12–15; 8:45 am]
methods of preventing or treating in advance of the meeting. BILLING CODE 4140–01–P

VerDate Sep<11>2014 16:56 Aug 12, 2015 Jkt 235001 PO 00000 Frm 00071 Fmt 4703 Sfmt 9990 E:\FR\FM\13AUN1.SGM 13AUN1

Document Created: 2018-02-23 10:56:54
Document Modified: 2018-02-23 10:56:54

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 10-11, 2015.
FR Citation		80 FR 48546

80 FR 48546 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 156 (August 13, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health